Immunolocalization of FAS and FAS ligand in inflammatory myopathies
✍ Scribed by Jan L. De Bleecker; Veronique I. Meire; Iris E. Van Walleghem; Iris M. Groessens; Michael J. Schröder
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 179 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0001-6322
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objective. To examine the expression of FasIFas ligand and the role of this ligand/receptor interaction in the regulation of apoptosis in normal human articular chondrocytes and in osteoarthritis (OA) cartilage. Methods. Normal and OA human knee cartilage and cells isolated from these tissues were
## Abstract ## BACKGROUND Tumor‐infiltrating, Fas ligand (FasL)‐expressing lymphocytes are able to eliminate Fas‐bearing tumor cells by apoptosis induction. Activated cytotoxic T‐cells that express Fas may enter apoptosis in the presence of FasL tumor cells. To date, no studies of patients with te